73 related articles for article (PubMed ID: 8465421)
1. Procoagulant properties of OKT3 at the monocyte level: inhibition by pentoxifylline.
Pradier O; Abramowicz D; Capel P; Goldman M
Transplant Proc; 1993 Apr; 25(2 Suppl 1):39-40. PubMed ID: 8465421
[No Abstract] [Full Text] [Related]
2. Interleukin-10 inhibits OKT3-induced cytokine release: in vitro comparison with pentoxifylline.
Schandené L; Gérard C; Crusiaux A; Abramowicz D; Velu T; Goldman M
Transplant Proc; 1993 Apr; 25(2 Suppl 1):55-6. PubMed ID: 8465427
[No Abstract] [Full Text] [Related]
3. [Inhibition by pentoxifylline of procoagulant activity produced by endotoxin-active monocytes].
de Prost D; Ollivier V; Hakim J
C R Seances Soc Biol Fil; 1992; 186(3):186-92. PubMed ID: 1283564
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline inhibition of procoagulant activity generated by activated mononuclear phagocytes.
De Prost D; Ollivier V; Hakim J
Mol Pharmacol; 1990 Oct; 38(4):562-6. PubMed ID: 1700271
[TBL] [Abstract][Full Text] [Related]
5. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
[TBL] [Abstract][Full Text] [Related]
6. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M
Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha is released by monocytes in OKT3 monoclonal antibody immunosuppressive therapy.
Urra JM; Peces R; Martinez-Naves E; Gutierrez V; Setién F; López-Larrea C
Transplant Proc; 1992 Dec; 24(6):2542-4. PubMed ID: 1465859
[No Abstract] [Full Text] [Related]
8. [Effect of platelet on procoagulant activity of monocyte].
Xu J; He X; Xiong S
Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):478-80. PubMed ID: 11758230
[TBL] [Abstract][Full Text] [Related]
9. Monocyte procoagulant activity induced by in vivo administration of the OKT3 monoclonal antibody.
Pradier O; Surquin M; Stordeur P; De Pauw L; Kinnaert P; Vereerstraeten P; Capel P; Goldman M; Abramowicz D
Blood; 1996 May; 87(9):3768-74. PubMed ID: 8611702
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline: a potential treatment for thrombosis associated with abnormal tissue factor expression by monocytes and endothelial cells.
de Prost D
J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S114-8. PubMed ID: 8699848
[TBL] [Abstract][Full Text] [Related]
11. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
Lackner KJ; von Landenberg C; Barlage S; Schmitz G
Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
[TBL] [Abstract][Full Text] [Related]
12. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
13. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
Hattori T; Khan MM; Colman RW; Edmunds LH
J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
[TBL] [Abstract][Full Text] [Related]
14. Discrepancy between tissue factor activity and tissue factor expression in endotoxin-induced monocytes is associated with apoptosis and necrosis.
Henriksson CE; Klingenberg O; Ovstebø R; Joø GB; Westvik AB; Kierulf P
Thromb Haemost; 2005 Dec; 94(6):1236-44. PubMed ID: 16411400
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte activation and leukocyte procoagulant activities after blood contact with polystyrene and polyethylene glycol-immobilized polystyrene beads.
Gorbet MB; Sefton MV
J Lab Clin Med; 2001 May; 137(5):345-55. PubMed ID: 11329532
[TBL] [Abstract][Full Text] [Related]
16. High-dose glucocorticosteroids increase the procoagulant effects of OKT3.
Abramowicz D; Pradier O; De Pauw L; Kinnaert P; Mat O; Surquin M; Doutrelepont JM; Vanherweghem JL; Capel P; Vereerstraeten P
Kidney Int; 1994 Dec; 46(6):1596-602. PubMed ID: 7700016
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 and pentoxifylline inhibit C-reactive protein-induced tissue factor gene expression in peripheral human blood monocytes.
Ramani M; Khechai F; Ollivier V; Ternisien C; Bridey F; Hakim J; de Prost D
FEBS Lett; 1994 Dec; 356(1):86-8. PubMed ID: 7988727
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A regulates monocyte/macrophage effector functions by affecting instructor T cells: inhibition of monocyte procoagulant response to allogeneic stimulation.
Helin HJ; Edgington TS
J Immunol; 1984 Mar; 132(3):1074-6. PubMed ID: 6229574
[No Abstract] [Full Text] [Related]
19. Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13.
Osnes LT; Westvik AB; Joø GB; Okkenhaug C; Kierulf P
Cytokine; 1996 Nov; 8(11):822-7. PubMed ID: 9047078
[TBL] [Abstract][Full Text] [Related]
20. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells.
Silva HM; Vieira PM; Costa PL; Pimentel BM; Moro AM; Kalil J; Maranhão AQ; Coelho V; Brigido MM
Immunol Lett; 2009 Aug; 125(2):129-36. PubMed ID: 19573559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
